An Open-Label, Multicenter Study to Determine Subject Satisfaction in Using the Single-Use Autoinjector With a Pre-Filled Liquid Avonex Syringe in Multiple Sclerosis Subjects.

Trial Profile

An Open-Label, Multicenter Study to Determine Subject Satisfaction in Using the Single-Use Autoinjector With a Pre-Filled Liquid Avonex Syringe in Multiple Sclerosis Subjects.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Biogen
  • Most Recent Events

    • 19 Feb 2010 Planned end date changed from 1 Jan 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.(NCT00828204)
    • 13 Aug 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 10 Jul 2009 Actual initiation date changed from Aug 2005 to Dec 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top